Have you suddenly developed hay fever? Have you had seasonal allergies, but it's progressively worsened in recent year?

Blueprint Medicines Corporation focuses on Ayvakit, BLU-808, and Elenestinib with strong potential in mast cell disorders.

According to the American College of Allergy Asthma and Immunology, nearly one in three U.S. adults report having a seasonal allergy, eczema or food allergy.

The following is a summary of “Prevalence of Mast Cell Activation Disorders and Hereditary Alpha Tryptasemia Amongst POTS and ...

Because of the often nonspecific nature of MCL, diagnostic efforts need to be better streamlined to reduce the risk of misdiagnosis.

Skin microbes do more than coexist—they shape immune responses, repair tissue, and influence gene expression across your ...

Raquel Rodriguez has lost many months of her WWE career due to her skin condition flaring up at very inopportune times. RAW ...

Raquel Rodriguez recently opened up about a skin condition during an interview on INSIGHT with Chris Van Vliet.

Cell polarity is the asymmetric organisation of several cellular components, including its plasma membrane, cytoskeleton or organelles. This asymmetry can be used for specialised functions, such ...

Blueprint Medicines' strong pipeline and Ayvakit growth make it promising. Read why BPMC stock is rated "Hold" due to high ...

Preclinical Work Advancing with Plans to Select a Next-Generation Oral Small Molecule PTH1R Agonist to Accelerate Toward the Clinic Later This Year Phase 1 Trial for SEP-631, MRGPRX2 NAM Program for ...

Hoth Therapeutics (HOTH) announced two major developments in the ongoing advancement of its proprietary antisense oligonucleotide, or ASO, ...